Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases. [electronic resource]
Producer: 20130614Description: 32 p. digitalISSN:- 1471-2407
- Acid Phosphatase -- metabolism
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antigens, CD34 -- metabolism
- Biomarkers, Tumor -- metabolism
- Bone Neoplasms -- enzymology
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Drug Administration Schedule
- Female
- Humans
- Immunohistochemistry
- Indoles -- administration & dosage
- Isoenzymes -- metabolism
- Mice
- Mice, Nude
- Protein Kinase Inhibitors -- administration & dosage
- Pyrroles -- administration & dosage
- Sunitinib
- Tartrate-Resistant Acid Phosphatase
- Time Factors
- Transfection
- Tumor Burden
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.